Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cridanimod can increase progesterone receptor (PR) expression, with potential antineoplastic adjuvant activity. Cridanimod is able to induce the expression of PR in endometrial cancer. In combination with a progestin, cancer cells could be eradicated through increased PR-mediated signaling, leading to an inhibition of luteinizing hormone release from the pituitary gland, via a negative feedback mechanism, and, eventually, an inhibition of estrogen released from the ovaries.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 78.00 | |
5 mg | 35 days | $ 233.00 | |
10 mg | 35 days | $ 383.00 |
Description | Cridanimod can increase progesterone receptor (PR) expression, with potential antineoplastic adjuvant activity. Cridanimod is able to induce the expression of PR in endometrial cancer. In combination with a progestin, cancer cells could be eradicated through increased PR-mediated signaling, leading to an inhibition of luteinizing hormone release from the pituitary gland, via a negative feedback mechanism, and, eventually, an inhibition of estrogen released from the ovaries. |
Synonyms | XBIO-101, XBIO 101, Cycloferon, Sodium Cridanimod, Cridanimod Na, XBIO101 |
Molecular Weight | 276.24 |
Formula | C15H11NNaO3 |
CAS No. | 58880-43-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cridanimod sodium 58880-43-6 XBIO-101 XBIO 101 Cycloferon Sodium Cridanimod Cridanimod Na XBIO101 inhibitor inhibit